IP Library › Assignment 041449/0799
Patent Assignment
Reel/Frame 041449/0799

Assignment of Assignor's Interest

Recorded: 2017-01-20 Pages: 29
Assignor
ALLERGAN FINANCE, LLC
Executed: 2016-07-19
Assignee
ACTAVIS HOLDCO US, INC.
400 INTERPACE PARKWAY, MORRIS CORPORATE CENTER III, PARSIPPANY, NEW JERSEY, 07054
Covered Properties (11)
Antioxidant Composition for Topical/Transdermal Prevention and Treatment of Wrinkles
Patent: 6,180,133 →
Application: 09/198,734 →
Compositions for Conjugated Estrogens and Associated Methods
Patent: 6,630,166 →
Application: 10/076,046 →
Novel Pharmaceutical Formulation Containing a Biguanide and a Thiazolidinedione Derivative
Patent: 7,785,627 →
Application: 10/664,803 →
Publication: US 2004/0106660
Novel Pharmaceutical Formulation Containing a Biguanide and a Thiazolidinedione Derivative
Patent: 7,959,946 →
Application: 10/777,542 →
Publication: US 2004/0161462
Oral Controlled Release Formulation for Sedative and Hypnotic Agents
Patent: 8,309,104 →
Application: 11/712,133 →
Publication: US 2007/0207203
Novel Pharmaceutical Formulation Containing a Biguanide and a Thiazolidinedione Derivative
Patent: 8,309,125 →
Application: 12/835,945 →
Publication: US 2010/0316708
Modified Release Tranexamic Acid Formulation
Patent: 8,597,683 →
Application: 12/956,036 →
Publication: US 2012/0135079
Novel Pharmaceutical Formulation Containing a Biguanide and a Thiazolidinedione Derivative
Patent: 8,470,368 →
Application: 13/151,653 →
Publication: US 2011/0262538
Novel Pharmaceutical Formulation Containing a Biguanide and a Thiazolidinedione Derivative
Patent: 8,668,931 →
Application: 13/889,441 →
Publication: US 2013/0266647
Modified Release Tranexamic Acid Formulation
Patent: 9,387,178 →
Application: 14/083,563 →
Publication: US 2014/0079779
Tablet
Patent: 440,650 →
Application: 29/117,422 →
Related Assignments (9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 30, 2010
From: JOSHI, MAYANK R.; FESHARAKI, SHAHIN
To: WATSON PHARMACEUTICALS, INC.
Reel/Frame 025430/0939 →
Change of Name Jul 2, 2013
From: WATSON PHARMACEUTICALS, INC.
To: ACTAVIS, INC.
Reel/Frame 030730/0468 →
Change of Name Jul 5, 2013
From: WATSON PHARMACEUTICALS, INC.
To: ACTAVIS, INC.
Reel/Frame 030741/0511 →
Change of Name Oct 16, 2013
From: WATSON PHARMACEUTICALS, INC.
To: ACTAVIS, INC.
Reel/Frame 031416/0863 →
Merger Feb 8, 2016
From: WATSON PHARMACEUTICALS, INC.
To: ACTAVIS, INC.
Reel/Frame 037687/0394 →
Merger Feb 10, 2016
From: WATSON PHARMACEUTICALS, INC.
To: ACTAVIS, INC.
Reel/Frame 037694/0761 →
Assignment of Assignor's Interest Feb 10, 2016
From: JOSHI, MAYANK R.; FESHARAKI, SHAHIN
To: WATSON PHARMACEUTICALS, INC.
Reel/Frame 037694/0223 →
Change of Name Jan 20, 2017
From: WATSON PHARMACEUTICALS, INC.
To: ACTAVIS, INC.
Reel/Frame 041023/0542 →
Change of Name Jan 20, 2017
From: ACTAVIS, INC.
To: ALLERGAN FINANCE, LLC
Reel/Frame 041459/0788 →